Atorvastatin Postpartum and Reduction of Cardiovascular Risk
Phase 4
76
about 1.2 years
20–50
Female only
1 site in OH
About this study
This trial is testing whether atorvastatin, a medication, reduces cardiovascular risk in postpartum women with hypertensive disorders of pregnancy. Women will be randomly assigned to either atorvastatin 10mg or a placebo after breastfeeding stops for three months.
Based on ClinicalTrials.gov records.
What participants do
- 1.Take Atorvastatin 10 mg
- 2.Take Placebo
Participation effort
Estimated from trial records. Details can vary by site.
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
atorvastatin (Statin; inhibits HMG-CoA reductase to lower cholesterol)
oral
Secondary: Estimated glomerular filtration rate, Fasting glucose, High-sensitivity C-reactive protein (Hs-CRP) level, Systolic blood pressure, Waist circumference
Reproductive Health, Cardiology / Heart